Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
The European Respiratory Journal
|
January 9, 2025
Pre-biologic disease trajectories are associated with morbidity burden and biologic treatment response in severe asthma
Marianne Baastrup Soendergaard, Frederikke Hjortdahl, Susanne Hansen, et al.
Allergy
|
December 14, 2024
Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe Asthma
Marianne Baastrup Soendergaard, Susanne Hansen, Kjell Erik Julius Håkansson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
July 15, 2025
Biologic Prescription Patterns and Biomarker Determinants of First-Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis
Marianne Baastrup Soendergaard, Kjell Erik Julius Håkansson, Susanne Hansen, et al.
BMJ Open Respiratory Research
|
September 29, 2023
Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study
Christian Kjer Heerfordt, Christian Rønn, Zitta Barrella Harboe, et al.
The European Respiratory Journal
|
November 27, 2025
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthma
Kjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard, et al.
Respiratory Medicine
|
June 13, 2025
Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register
Susanne Hansen, Kjell Erik Julius Håkansson, Marianne Baastrup Soendergaard, et al.
Trials
|
September 2, 2025
Study protocol: COPD-eosinophil-guided reduction of inhaled corticosteroids (COPERNICOS) : A randomized, double-blinded, multicenter, four-arm intervention clinical trial on eosinophil-guided time-updated person-specific reduction of inhaled corticosteroid therapy and prophylactic low dose Azithromycin therapy in patients with severe or very severe chronic obstructive pulmonary disease (COPD)
Christian Rønn, Barbara Bonnesen, Imane Achir Alispahic, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
February 25, 2025
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthma
Kjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
BMJ Open Respiratory Research
|
March 5, 2026
Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysis
Kjell E J Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Pulmonology
|
July 21, 2025
Financial burden of productivity loss in severe asthma and impact of biologic therapy
Kjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
The European Respiratory Journal
|
January 9, 2025
Pre-biologic disease trajectories are associated with morbidity burden and biologic treatment response in severe asthma
Marianne Baastrup Soendergaard, Frederikke Hjortdahl, Susanne Hansen, et al.
Allergy
|
December 14, 2024
Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe Asthma
Marianne Baastrup Soendergaard, Susanne Hansen, Kjell Erik Julius Håkansson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
July 15, 2025
Biologic Prescription Patterns and Biomarker Determinants of First-Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis
Marianne Baastrup Soendergaard, Kjell Erik Julius Håkansson, Susanne Hansen, et al.
BMJ Open Respiratory Research
|
September 29, 2023
Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study
Christian Kjer Heerfordt, Christian Rønn, Zitta Barrella Harboe, et al.
The European Respiratory Journal
|
November 27, 2025
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthma
Kjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard, et al.
Respiratory Medicine
|
June 13, 2025
Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register
Susanne Hansen, Kjell Erik Julius Håkansson, Marianne Baastrup Soendergaard, et al.
Trials
|
September 2, 2025
Study protocol: COPD-eosinophil-guided reduction of inhaled corticosteroids (COPERNICOS) : A randomized, double-blinded, multicenter, four-arm intervention clinical trial on eosinophil-guided time-updated person-specific reduction of inhaled corticosteroid therapy and prophylactic low dose Azithromycin therapy in patients with severe or very severe chronic obstructive pulmonary disease (COPD)
Christian Rønn, Barbara Bonnesen, Imane Achir Alispahic, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
February 25, 2025
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthma
Kjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
BMJ Open Respiratory Research
|
March 5, 2026
Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysis
Kjell E J Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Pulmonology
|
July 21, 2025
Financial burden of productivity loss in severe asthma and impact of biologic therapy
Kjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Page
of 4